Challenges of COVID-19 for Fair Trade enterprises in attaining Sustainable Development Goals 2030
Journal of Fair Trade · 2021
DOI: 10.13169/jfairtrade.3.1.0044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fair Trade, 2021. Verfasst von Jeetendra Dangol und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper aims to explore challenges of COVID-19 in achieving sustainable development goal (SDG) 1 ‘no poverty’ by Fair Trade (FT) enterprises. The authors used focus group discussion (FGD) with seven members of World Fair Trade Organisation (WFTO) – Asia, from six different countries: Thailand, Bangladesh, Nepal, India, the Philippines, and Indonesia. Findings suggest that COVID-19 has posed bigger challenges to FT enterprises in achieving the SDGs since the pandemic has created challenges not only to the economic aspect but also to the health, education, safety and security of the communities. Due to COVID-19, the progress in attaining SDGs has slowed down, as global unemployment surged, global markets collapsed with a catastrophic economic downturn, which could eventually push more people to the pit of poverty. Stronger collaboration among the stakeholders is needed to achieve the SDGs.
Zitieren
APA
Dangol, J., & Chitrakar, S. (2021). Challenges of COVID-19 for Fair Trade enterprises in attaining Sustainable Development Goals 2030. Journal of Fair Trade. https://doi.org/10.13169/jfairtrade.3.1.0044
Vancouver
Dangol J, Chitrakar S. Challenges of COVID-19 for Fair Trade enterprises in attaining Sustainable Development Goals 2030. Journal of Fair Trade. 2021. doi:10.13169/jfairtrade.3.1.0044
BibTeX
@article{Dangol2021,
author = {Dangol, Jeetendra and Chitrakar, Sunil},
title = {Challenges of COVID-19 for Fair Trade enterprises in attaining Sustainable Development Goals 2030},
journal = {Journal of Fair Trade},
year = {2021},
doi = {10.13169/jfairtrade.3.1.0044}
}
EUVIMED